Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow Quality Index
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Quality Index of 1.44x as of December 2025. Operating cash flow of CN¥106.82 Million exceeds net income of CN¥74.10 Million, indicating high earnings quality where cash backs reported profits. Explore Jianmin Pharmaceutical Group Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jianmin Pharmaceutical Group Co Ltd Cash Flow Quality Index (2003–2025)
Historical Cash Flow Quality Index for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Jianmin Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year earnings quality comparison for Jianmin Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see market value of Jianmin Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | CN¥274.53 Million | CN¥359.84 Million | ▲ +17.9% |
| 2024 | 0.65x | CN¥234.27 Million | CN¥362.18 Million | ▲ +26.1% |
| 2023 | 0.51x | CN¥268.39 Million | CN¥523.23 Million | ▼ -3.6% |
| 2022 | 0.53x | CN¥215.87 Million | CN¥405.50 Million | ▼ -33.2% |
| 2021 | 0.80x | CN¥259.18 Million | CN¥325.42 Million | ▼ -5.7% |
| 2020 | 0.84x | CN¥125.54 Million | CN¥148.69 Million | ▲ +5.1% |
| 2019 | 0.80x | CN¥74.45 Million | CN¥92.63 Million | ▲ +2.7% |
| 2018 | 0.78x | CN¥63.60 Million | CN¥81.30 Million | ▲ +103.2% |
| 2017 | 0.38x | CN¥35.20 Million | CN¥91.44 Million | ▼ -78.0% |
| 2016 | 1.75x | CN¥113.84 Million | CN¥65.06 Million | ▲ +214.2% |
| 2015 | 0.56x | CN¥48.45 Million | CN¥87.00 Million | ▼ -35.8% |
| 2014 | 0.87x | CN¥103.23 Million | CN¥118.95 Million | ▲ +84.1% |
| 2013 | 0.47x | CN¥45.36 Million | CN¥96.20 Million | ▼ -60.4% |
| 2012 | 1.19x | CN¥98.17 Million | CN¥82.54 Million | ▲ +223.3% |
| 2011 | -0.97x | CN¥-75.54 Million | CN¥78.28 Million | ▼ -144.0% |
| 2010 | 2.19x | CN¥150.08 Million | CN¥68.50 Million | ▲ +52.5% |
| 2009 | 1.44x | CN¥66.69 Million | CN¥46.42 Million | ▼ -79.7% |
| 2008 | 7.08x | CN¥110.11 Million | CN¥15.55 Million | ▲ +1002.6% |
| 2007 | -0.78x | CN¥-6.88 Million | CN¥8.77 Million | ▼ -118.9% |
| 2006 | 4.15x | CN¥56.18 Million | CN¥13.55 Million | ▲ +394.8% |
| 2005 | -1.41x | CN¥-34.63 Million | CN¥24.62 Million | ▼ -1161.9% |
| 2004 | 0.13x | CN¥4.13 Million | CN¥31.20 Million | ▼ -10.3% |
| 2003 | 0.15x | CN¥4.19 Million | CN¥28.35 Million | — |